<?xml version="1.0" encoding="UTF-8"?>
<p>Although the first EV-A71 vaccine was already on the market in China, this vaccine could not protect against other novel emerging etiologies of HFMD. Hence, there is no general vaccine available for HFMD [
 <xref rid="pntd.0008085.ref014" ref-type="bibr">14</xref>,
 <xref rid="pntd.0008085.ref015" ref-type="bibr">15</xref>]. Therefore, identifying its influencing factors and working toward early warning and timely prevention are still the keys to reducing the severity of the incidence of HFMD [
 <xref rid="pntd.0008085.ref016" ref-type="bibr">16</xref>].
</p>
